Medicare Drug Savings Act of 2017 [S.252]
Medicare Drug Savings Act of 2017 This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP). Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
S.252: Medicare Drug Savings Act of 2017
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Finance. on 02/01/2017
HB-797: To amend title XIX of the Social Security Act to remove the matching requirement for a territory to use specially allocated Federal funds for Medicare covered part D drugs for low-income individuals.
Sponsored by: Rep. Amata Radewagen
Referred To The Subcommittee On Health. on 02/03/2017
You have voted HB-797: To amend title XIX of the Social Security Act to remove the matching requirement for a territory to use specially allocated Federal funds for Medicare covered part D drugs for low-income individuals..
Postal Service Reform Act of 2017 [HB-756]
Postal Service Reform Act of 2017 TITLE I--POSTAL SERVICE BENEFITS REFORM This bill requires the Office of Personnel Management (OPM) to establish a Postal Service Health Benefits Program within the Federal Employees Health Benefits Program to offer health benefits plans for U.S. Postal Service (USPS) employees, annuitant retirees, and their families at rates that reflect the cost of benefits provided solely to the USPS risk pool. Medicare-eligible postal retirees and family members are automatically enrolled in part A (Hospital Insurance) and part
(continued...)
HB-756: Postal Service Reform Act of 2017
Sponsored by: Rep. Steve Russell
Assuming First Sponsorship - Mr. Garrett Asked Unanimous Consent That He May Hereafter Be Considered As The First Sponsor Of H.r. 756, A Bill Originally Introduced By Former Representative Chaffetz, For Purposes Of Adding Cosponsors And Requesting Reprintings Pursuant To Clause 7 Of Rule Xii. Agreed To Without Objection. on 03/20/2018
Lower Drug Costs through Competition Act [HB-749]
Lower Drug Costs through Competition Act This bill amends the Federal Food, Drug, and Cosmetic Act to revise provisions regarding review and approval of generic drug applications or supplements to generic drug applications for drugs: (1) for which there is a shortage, or (2) that have not been recently introduced to the market by more than one manufacturer and for which tentative approval has not been granted to more than two applications. The Food and Drug Administration (FDA) must prioritize the review of such submissions and act on them within
(continued...)
HB-749: Lower Drug Costs through Competition Act
Sponsored by: Rep. Gus Bilirakis
Referred To The Subcommittee On Health. on 02/03/2017
Compassionate Access Act [HB-715]
Compassionate Access Act This bill directs the Department of Health and Human Services to submit to the Drug Enforcement Administration (DEA) a recommendation to transfer marijuana from schedule I to another controlled substances schedule. The DEA must consider the recommendation and issue a final rule to reclassify marijuana. It permits, for reclassification purposes, consideration of scientifically sound research conducted in a state that allows medical marijuana and in accordance with state law, even if such research uses non-federally approved
(continued...)
HB-715: Compassionate Access Act
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations. on 02/14/2017
LUMMA Legitimate Use of Medicinal Marihuana Act [HB-714]
LUMMA Legitimate Use of Medicinal Marihuana Act This bill transfers marijuana from schedule I to schedule II of the Controlled Substances Act. It specifies that no provision of the Controlled Substances Act prohibits or restricts activities related to medical marijuana that comply with a state's medical marijuana law. This bill does not affect any federal, state, or local law that regulates or prohibits smoking in public.
HB-714: LUMMA Legitimate Use of Medicinal Marihuana Act
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Health. on 02/03/2017
Fairness to Pet Owners Act of 2017 [HB-623]
Fairness to Pet Owners Act of 2017 This bill directs the Federal Trade Commission to require prescribers of animal drugs to verify prescriptions and provide copies of prescriptions to pet owners, pet owner designees, and pharmacies, without the prescriber demanding payment or establishing other conditions. The bill applies these requirements to medication for a domesticated household animal that consumers are not allowed to purchase without a prescription. A violation of this bill shall be treated as an unfair or deceptive act or practice under
(continued...)
HB-623: Fairness to Pet Owners Act of 2017
Sponsored by: Rep. Matthew Cartwright
Introduced In House on 01/24/2017
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 [S.204]
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to exempt, from specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must report annually to the Food and
(continued...)
S.204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Sponsored by: Sen. Chuck Grassley
Became Public Law No: 115-176. on 05/30/2018
Obamacare Replacement Act [S.222]
Obamacare Replacement Act This bill amends the Internal Revenue Code, the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Social Security Act to repeal certain provisions regarding health insurance, including: the requirement for individuals to maintain minimum essential coverage, limitations on insurers varying premiums by age or health status, requirements for health insurance to cover preexisting conditions and the essential health benefits, and the prohibition on lifetime or annual limits on benefits.
(continued...)
S.222: Obamacare Replacement Act
Sponsored by: Sen. Rand Paul
Read Twice And Referred To The Committee On Finance. on 01/24/2017
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act [HB-635]
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to offer, throughout the United States, a public health insurance option that provides value, choice, competition, and the stability of affordable, high-quality coverage. Plans under the public health insurance option must be qualified health plans and must include plans with bronze, silver, and gold tier benefits. (Qualified health plans are sold on health insurance
(continued...)
HB-635: CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act
Sponsored by: Rep. Raul Grijalva
Introduced In House on 01/24/2017
Expanded & Improved Medicare For All Act [HB-676]
Expanded & Improved Medicare For All Act This bill establishes the Medicare for All Program to provide all individuals residing in the United States and U.S. territories with free health care that includes all medically necessary care, such as primary care and prevention, dietary and nutritional therapies, prescription drugs, emergency care, long-term care, mental health services, dental services, and vision care. Only public or nonprofit institutions may participate. Nonprofit health maintenance organizations (HMOs) that deliver care in their own
(continued...)
HB-676: Expanded & Improved Medicare For All Act
Sponsored by: Rep. Raul Grijalva
Assuming First Sponsorship - Mr. Ellison Asked Unanimous Consent That He May Hereafter Be Considered As The First Sponsor Of H.r. 676, A Bill Originally Introduced By Former Representative Conyers, For Purposes Of Adding Cosponsors And Requesting Reprintings Pursuant To Clause 7 Of Rule Xii. Agreed To Without Objection. on 03/07/2018
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act [S.194]
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to offer, throughout the United States, a public health insurance option that provides value, choice, competition, and the stability of affordable, high-quality coverage. Plans under the public health insurance option must be qualified health plans and must include plans with bronze, silver, and gold tier benefits. (Qualified health plans are sold on health insurance
(continued...)
S.194: CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/23/2017
Short on Competition Act [S.183]
Short on Competition Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to authorize importation of life-saving drugs for which there is, or is likely to be, a shortage. For a drug to be imported, the drug's manufacturer must intend to seek FDA approval of the drug as a generic drug. The FDA may deny importation of a drug for reasons related to safety or effectiveness. Drugs in noncompetitive markets must be treated as being in a shortage for purposes of this bill and for purposes of expedited
(continued...)
S.183: Short on Competition Act
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/20/2017
Pharmacy and Medically Underserved Areas Enhancement Act [HB-592]
Pharmacy and Medically Underserved Areas Enhancement Act This bill amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage and payment with respect to certain pharmacist services that: (1) are furnished by a pharmacist in a health-professional shortage area, and (2) would otherwise be covered under Medicare if furnished by a physician.
HB-592: Pharmacy and Medically Underserved Areas Enhancement Act
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 02/01/2017
Preserve Access to Affordable Generics Act [S.124]
Preserve Access to Affordable Generics Act This bill amends the Federal Trade Commission Act to authorize the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug. Such an agreement, with specified exceptions, is presumed to have anticompetitive effects and is a violation of this bill if the filer of the abbreviated new drug (generic) application receives anything of value and agrees to limit or forego research, development,
(continued...)
S.124: Preserve Access to Affordable Generics Act
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On The Judiciary. on 01/12/2017
Pharmacy and Medically Underserved Areas Enhancement Act [S.109]
Pharmacy and Medically Underserved Areas Enhancement Act This bill amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage and payment with respect to certain pharmacist services that: (1) are furnished by a pharmacist in a health-professional shortage area, and (2) would otherwise be covered under Medicare if furnished by a physician.
S.109: Pharmacy and Medically Underserved Areas Enhancement Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Finance. on 01/12/2017
Allowing Greater Access to Safe and Effective Contraception Act [HB-421]
Allowing Greater Access to Safe and Effective Contraception Act This bill requires the Food and Drug Administration (FDA) to prioritize review of supplemental drug applications (applications to modify the approved use of a drug) for contraceptive drugs intended for routine use that would be available to individuals aged 18 and older without a prescription. The FDA must waive user fees for such supplemental drug applications. Any drug that is eligible for this priority review must be a prescription drug for individuals under age 18. This bill repeals
(continued...)
HB-421: Allowing Greater Access to Safe and Effective Contraception Act
Sponsored by: Rep. Barbara Comstock
Referred To The Subcommittee On Health. on 01/26/2017
Veteran Suicide Prevention Act [HB-411]
Veteran Suicide Prevention Act This bill directs the Department of Veterans Affairs (VA) to complete a publicly available review of the deaths of all covered veterans who died by suicide during the preceding five-year period. Such review shall include: the total number of veterans who died by suicide during the five-year period; a summary that includes age, gender, and race; a list of the medications prescribed to, and found in the systems of, such veterans at the time of their deaths, and a summary of medical diagnoses by VA physicians which led
(continued...)
HB-411: Veteran Suicide Prevention Act
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Health. on 02/03/2017
Safe and Affordable Drugs from Canada Act of 2017 [S.92]
Safe and Affordable Drugs from Canada Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 185 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that: is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States;
(continued...)
S.92: Safe and Affordable Drugs from Canada Act of 2017
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/10/2017
Restoring Access to Medication Act of 2017 [HB-394]
Restoring Access to Medication Act of 2017 This bill repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that limit payments for medications from health savings accounts, medical savings accounts, and health flexible spending arrangements to only prescription drugs or insulin (thus allowing distributions from such accounts for over-the-counter drugs).
HB-394: Restoring Access to Medication Act of 2017
Sponsored by: Rep. Barbara Comstock
Introduced In House on 01/10/2017